Dual PI3 K/mTOR Inhibition Reduces Prostate Cancer Bone Engraftment Altering Tumor-Induced Bone Remodeling

Tumor Biology - United States
doi 10.1177/1010428318771773
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Targeting Factors Involved in Bone Remodeling as Treatment Strategies in Prostate Cancer Bone Metastasis

Clinical Cancer Research
Cancer ResearchOncology
2006English

A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain

Journal of Pain
NeurologyAnesthesiologyPain Medicine
2018English

Targeting Cathepsin K Diminishes Prostate Cancer Establishment and Growth in Murine Bone

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2019English

Dual Inhibition of ULK1 and mTOR Enhances Tumor Cell Apoptosis

Cancer Discovery
Oncology
2015English

Bone-Targeted Therapies in Cancer-Induced Bone Disease

Calcified Tissue International
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2017English

Interactions Between Cancer Cells and Bone Microenvironment Promote Bone Metastasis in Prostate Cancer

Cancer Communications
Cancer ResearchOncology
2019English

Targeted Inhibition of Cell-Surface Serine Protease Hepsin Blocks Prostate Cancer Bone Metastasis

Oncotarget
Oncology
2014English

Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling

PLoS ONE
Multidisciplinary
2013English

Breast Cancer-Induced Bone Remodeling, Skeletal Pain, and Sprouting of Sensory Nerve Fibers

Journal of Pain
NeurologyAnesthesiologyPain Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy